IDH1 and central nervous system cancer: Most studies have demonstrated that IDH1 mutation plays a key role in the tumorigenesis and progression of glioma by DNA hypermethylation, histone hypermethylation, hypoxia-inducible factor-1a level changes, and oxidative stress mechanisms (51, 52).